FORT LAUDERDALE, Fla., Dec. 1, 2020 /PRNewswire-PRWeb/ -- USARAD Holdings Inc., the leading US Joint Commission Accredited teleradiology and telemedicine company announces during RSNA 2020 virtual conference issuance of a new utility patent. As a next-generation radiology and telemedicine company, USARAD embraces Radiology-as-a-service business strategy by leveraging new technologies such as AI and Blockchain in combination with novel ultra-low-cost ultrasound and digital x-ray-based imaging devices. USARAD expands its relationships with several technology partners including Nano-x Imaging Ltd.. USPTO issued patent # US10,803,985, "Method of facilitating Imaging Study Interpretations between Healthcare Facilities and Physicians Including Customization of Imaging Studies" on October 13, 2020. The patent, which was filed 2 years prior, is assigned to its partner, MDW.io, licensed to USARAD Holdings, and is a part of a patent portfolio with multiple additional pending patents.
New Traders Swear By Benzinga Options
We sift through this volatile market for consistent trades so you don't have to. Get Benzinga Options: Starter Edition to follow Benzinga's high-conviction options trades.

Ad Statistics
Times Displayed: 50213
Times Visited: 1424 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The patent describes a unique decentralized method of matching radiologists with medical imaging facilities and AI companies. It also describes a method of conducting immediate financial transactions between all stakeholders to provide fast and efficient AI development and teleradiology workflow. The method includes receiving physician credentials from radiologists and imaging studies from healthcare facilities, request for interpretation of the imaging studies, annotation requirements of AI companies, physician selection criteria, access to the imaging study and request for interpretation or annotations to qualified physicians whose credentials match the physician selection criteria.
The patent and clinically validated, fully built-out MDW platform provide all participating stakeholders with a secure, simple and cost-effective way to conduct healthcare transactions. The platform offers an efficient way to harness the power of community to generate interpretations and consultations using blockchain technology. It enables any party, including referring physicians, radiologists, diagnostic facilities, as well as insurance companies to request interpretations from platform participants and through execution of smart contracts insure immediate payments to one or multiple parties, for example those who improve on the original interpretations.